Publication | Open Access

Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial

Drug SafetyPrevent Gastroduodenal EventsRivaroxaban And/or AspirinPatient SafetyGastroenterologyPharmacologyPlacebo-controlled TrialPharmacotherapyPharmacologic InterventionMedicineAdverse Drug ReactionSide Effect